Showing results (161-170 of 175) with videos related to
Sort By:
Pageof 18
Molecular and Clinical Oncology|December 14, 2019
Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancerTakafumi Watanabe, Shu Soeda, Hiroshi Nishiyama, et al.Cancer Science|February 19, 2021
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancerAtsushi Fujii, Takaaki Masuda, Michio Iwata, et al.Annals of Surgical Oncology|July 2, 2016
Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric CancerMitsuro Kanda, Dai Shimizu, Tsutomu Fujii, et al.Cancer Genomics & Proteomics|February 29, 2020
KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular CarcinomaAkihiro Kitagawa, Takaaki Masuda, Junichi Takahashi, et al.The Tohoku Journal of Experimental Medicine|August 28, 2015
CRP 1846C>T Genetic Polymorphism Is Associated with Lymph Node Metastasis and/or Severe Lymphatic Invasion in Endometrial CancerMasahiko Kito, Satoru Motoyama, Kazuma Fujita, et al.International Journal of Clinical Oncology|January 20, 2016
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit StudyMasahiro Kagabu, Tadahiro Shoji, Kazuyuki Murakami, et al.International Journal of Clinical Oncology|October 10, 2022
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.Cancers|November 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.Elife|October 20, 2023
Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes the generation of the whole lungAkihiro Miura, Hemanta Sarmah, Junichi Tanaka, et al.Annals of Surgical Oncology|November 11, 2023
Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal MetastasisDaisuke Kobayashi, Yasuhiro Kodera, Ryoji Fukushima, et al.Pageof 18